Bull & Bear

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the spread between $2.24 and pro-forma cash is wide enough that even a bear-haircut sum-of-parts clears the current price, but the entire trade hinges on one PRC anti-monopoly decision and a controlled-board capital-return promise that, today, is just a press release. At $485M of market cap against US$717M of buyer cash and US$997M of total expected proceeds plus pre-existing net cash of roughly US$465M [1], the market is paying roughly 33–50 cents on the dollar to underwrite SAMR clearance and the conversion of "substantial majority of the proceeds" into actual ADS-holder cash. The decisive tension is not whether the bull math is real — it is — but whether SAMR clears the transfer of a leading independent dark-front-grocery operator to the buyer that already runs the dominant rider network and a competing Xiaoxiang DFG footprint, and whether the 80.9%-vote founder uses the proceeds to retire the float he can no longer monetize any other way. The signals that would resolve the trade are concrete and dated: a SAMR clearance announcement, plus a board resolution that translates "substantial majority" into a dollar amount, instrument, and timetable.

Bull Case

The strongest three points from Bull's draft. The first builds the arithmetic; the second sets the structural floor; the third frames why the residual founder is now mechanically aligned with the float. The 2026 Q1 release confirms the held-for-sale RMB138 million quarterly lift and that the Meituan transaction remains subject to SAMR clearance [2]. Founder Liang's 25.2% economic / 80.9% voting position is disclosed in the FY2025 20-F [3], and the company's pre-existing parent-level net cash of RMB3,210.6 million (twelfth consecutive quarter of growth) was reported at March 31, 2026 [4].

No Results

Bull's price target is US$4.25 per ADS (roughly 90% upside from $2.24 on 2026-06-17), built as pro-forma sum-of-parts: existing net cash plus 75%-realization on the Meituan consideration, less corporate burn through closing, divided by ~216.7M ADS, with the overseas stub treated as zero-cost optionality. Bull's timeline is 12–18 months, anchored on the SPA's 12-month termination clause and the August 31, 2026 BVI cash-extraction milestone. The primary catalyst is a definitive SAMR anti-monopoly clearance, and the disconfirming signal is either a formal SAMR rejection or a board resolution that redefines "substantial majority" to exclude more than 50% of proceeds.

Bear Case

The strongest three points from Bear's draft. Each is a different way of arguing that what looks like asymmetric upside is actually compensation for stacked, correlated risks. The held-for-sale RMB138 million net-income lift is disclosed in the Q1 FY2026 release [2], overseas Q1 net loss widened 199.6% year-over-year [5], and the FY2025 20-F shows the 2025 ADS buyback authorization of US$20 million was executed at 695,957 ADS at an average price of US$1.78 — about US$1.24 million, or 6.2% of the authorization [6].

No Results

Bear's downside target is US$1.60 per ADS (about -29% from $2.24), built as a probability-weighted SOTP across a 45% SAMR break / 40% messy-close-with-leakage / 15% clean-close mix. Timeline is 12–15 months, set by the same SPA walk-away clock that bounds the bull. The primary trigger is a SAMR review milestone — extended consultation, conditional remedy demand, or outright block. The cover signal is a definitive SAMR clearance combined with a board-authorized capital-return plan stating a dollar amount, instrument (special dividend versus tender), and execution timetable — both legs required.

The Real Debate

Two tensions decide the trade, and both are observable. The Q1 FY2026 release pins the SPA's SAMR-clearance condition and the "substantial majority" commitment to the primary record [2]; the FY2025 20-F supplies the SPA terms (US$717M, up to US$280M pre-close BVI extraction, US$150M net-cash floor) and the 2025 buyback execution that anchors the capital-return debate [1] [6].

No Results

Verdict

Lean Long, Wait For Confirmation. Bull's arithmetic is too wide to ignore: even after the bear's haircuts — a partial SAMR remedy, 10% withholding leakage, the 10% post-tax holdback, and 30–50% leakage from "substantial majority" — the implied recovery clears the current $2.24 ADS price, and the pre-existing parent-level net cash floors the equity at roughly $2.07 per ADS [4]. The single most important tension is SAMR: the equity will not re-rate to pro-forma cash without clearance, and that is the durable variable — not a quarter's print, not a held-for-sale accounting bump. Bear can still be right because the buyer is the worst possible counterparty in this category, and a controlled board with a 6.2%-execution buyback record is a credible reason to discount the press-release promise even after clearance. The verdict flips on either (1) a definitive SAMR rejection or remedy that strips more than half the deal value (durable thesis breaker), or (2) the board redirecting "substantial majority" into multi-year overseas capex rather than buyback or dividend (use-of-proceeds breaker). The near-term evidence marker — distinct from the thesis breaker — is the first procedural milestone in the SAMR review and a Q2 or Q3 board resolution that translates "substantial majority" into a dollar amount and instrument. Until those land, position behavior should treat this as event-driven optionality, not a fundamental long.

Lean Long, Wait For Confirmation — the spread to pro-forma cash is structurally wide, but the trade only completes on a definitive SAMR clearance plus a board-authorized capital-return plan with a stated dollar amount and timetable.

References

Generated Jun 19, 2026 10:16 UTC